Position in MRKR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$366,651
+$138,769 QoQ
Shares Held
249,423
+42.3% QoQ
Ownership
1.50%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 35 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRKR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,593,796 across 312 Biotechnology names. MRKR ranks #229 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in MRKR
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $366,651 | 249,423 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $227,882 | 175,294 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $184,238 | 123,650 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $94,562 | 106,250 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $106,246 | 69,442 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $102,723 | 83,515 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $124,555 | 40,050 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $112,095 | 39,750 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $210,955 | 38,850 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $160,175 | 37,250 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $206,525 | 37,550 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $182,735 | 40,250 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $99,045 | 31,950 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $13,738 | 19,350 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $44,064 | 163,200 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $56,055 | 151,500 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $88,341 | 267,700 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $257,079 | 584,272 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,015,550 | 1,069,000 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,664,819 | 985,100 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,115,721 | 399,900 | Shares | Sole | 2021-08-13 | |
| 2020-12-31 | $461,622 | 318,360 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $340,504 | 227,003 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $661,607 | 319,617 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $445,922 | 234,696 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||